Design of a Microfluidic Bleeding Chip to Evaluate Antithrombotic Agents for Use in COVID-19 Patients

INTRODUCTION: Interventions that could prevent thrombosis, clinical decompensation, and respiratory compromise in patients with novel coronavirus disease (COVID-19) are key to decrease mortality rate. Studies show that profound cytokine release and excessive activation of blood coagulation appear to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lakshmanan, Hari Hara Sudhan, Pore, Adity A., Kohs, Tia C. L., Yazar, Feyza, Thompson, Rachel M., Jurney, Patrick L., Maddala, Jeevan, Olson, Sven R., Shatzel, Joseph J., Vanapalli, Siva A., McCarty, Owen J. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408976/
https://www.ncbi.nlm.nih.gov/pubmed/32837586
http://dx.doi.org/10.1007/s12195-020-00644-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408976/
https://www.ncbi.nlm.nih.gov/pubmed/32837586
http://dx.doi.org/10.1007/s12195-020-00644-x

Ejemplares similares